CD274 and colorectal carcinoma: Additional evidence has confirmed the synergistic therapeutic effects of combining NCP@pyrolipid-PDT with anti-PD-L1 therapy, resulting in the inhibition of primary CRC growth and suppression of distant metastasis 94.